Clinical Trial Update: Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a GLP-1 receptor agonist for adults with obesity-related, symptomatic asthma. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GLP-1 receptor agonist (unspecified)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Asthma | Phase 2 | Status: RECRUITING